Welcome to the Bio-based Material Quarterly Newsletter Q2 2023.
Policy
China launched the Measures for the Administration of the Use and Reporting of Disposable Plastic Products by Business Operators in the Commercial Sector, effective as of 20 June, 2023, to ban or strictly regulate the uses of non-degradable plastic bags and other disposable plastic items.
Market dynamics & company performance
In the quarter, Kingfa's 50,000 t/a L-lactic acid project and the 10,000 t/a bio-based 1,4-butanediol (BDO) project broke ground; Sulzer and Jindan New Biomaterials started cooperation in polylactic acid (PLA); Cathay Biotech, East China University of Science and Technology and Lund University jointly published breakthrough study on lignocellulose-derived D-lactide production; and progresses have been made of the PLA-related projects of Changchun Institute of Applied Chemistry (CIAC), Ma'anshan Tong-Jie-Liang Biomaterials, Shandong Guyu and Guangdong Sisan.
In furans area, GS Biotech's bio-based degradable materials production project was approved on the environmental issue; Leaf Biotech's 2,5-furandicarboxylic acid (FDCA) industrial production project received funding from two RMB200 million series B rounds; CTA and Sugar Energy started to co-develop bio-based PEF synthesis; CellUranics' and Panjin Sanli's FDCA R&D projects were also posted with further details.
More are included: Weiqi Biotech's 30,000 t/a PHA production base project started construction; Bluepha and TotalEnergies Corbion started cooperation in PLA and PHA application development; Huaheng Biotech proposed financing to build capacities of 50,000 t/a bio-based succinic acid (SA) and 50,000 t/a bio-based malic acid (MA); Taixing Lianxin's 25,000 t/a carbon-based biodegradable plastics project was approved for construction; Liangyungang Juwei Yuanchuang raised plan to set up 12,000 t/a SA capacity; Suzhou Sipeng Technology's biosynthesis and biomaterials application project was accepted; Homelink proposed financing to build 100,000 t/a sugarcane bagasse-derived material capacity; Xinxiang Chemical's 5,000 t/a Juncao-derived fibre pilot-scale experiment was approved.
Price
In the period of Q2, there was a general decline in the PLA prices, while the PHA prices have remained flat.
The USD/CNY exchange rate in this newsletter is USD1.00=CNY7.0965 on 1 June, 2023, sourced from the People's Bank of China. Unless otherwise specified, all the prices mentioned in this newsletter will include the VAT.
- Administrative measures for business use and reporting of disposable plastics
- Kingfa's growths in 2022 and Q1 2023 slow down
- Huaheng Biotech calls for USD237.94 million funding for bio-based product projects
- Sulzer signs PLA technology supply agreement with Jindan New Biomaterials
- Updates of China's PLA projects in Q2
- Weiqi Biotech breaks ground on 30,000 t/a PHA production base
- Jiangsu Jinghong to found 55,000 t/a PLA capacity
- GS Biotech's recent development of bio-based furans projects
- Taixing Lianxin's 25,000 t/a carbon-based biodegradable plastics project approved
- Industrialisation progress of FDCA in China in Q2
- Bluepha and TotalEnergies Corbion enter cooperation in PLA and PHA development
- Suzhou Sipeng Technology planning biosynthesis and biomaterials application project
- Liangyungang Juwei Yuanchuang to build succinic acid project
- Homelink proposes USD105.69 million funding for sugarcane bagasse-derived material project
- CTA and Sugar Energy join hands for bio-based PEF synthesis development
- Xinxiang Chemical to commence Juncao-derived fibre pilot-scale experiment
- Cathay Biotech's study on lignocellulose-derived D-lactide

